Actively Recruiting
Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Led by Tabba Heart Institute · Updated on 2023-04-07
2000
Participants Needed
1
Research Sites
294 weeks
Total Duration
On this page
Sponsors
T
Tabba Heart Institute
Lead Sponsor
G
Getz Pharma
Collaborating Sponsor
AI-Summary
What this Trial Is About
Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk is higher in Pakistanis than in Indians-the two largest SA groups. Pakistan is the 5th most populous country in the world, and despite these concerning trends, so far there has been a scarcity of large studies evaluating the prevalence of cardiovascular risk factors and subclinical coronary atherosclerosis in young-to-middle-aged Pakistanis. Also, there is currently no cardiovascular risk score specifically tailored to younger Pakistani men and women. The PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT) aims at addressing these important gaps. PAK-SEHAT is an ongoing prospective cohort study that will enroll 2,000 asymptomatic Pakistani men aged 35 to 60 years and women aged 35 to 65 years from the general population, free of clinically overt cardiovascular disease. Participants will undergo a comprehensive baseline exam including coronary computed tomography angiography, and will be followed for incident events and repeat testing for 5 years. PAK-SEHAT will allow determining the prevalence, severity, determinants, and prognostic significance of early atherosclerosis in apparently healthy young-to-middle-aged Pakistanis. This knowledge can help inform primordial and primary prevention strategies, enhanced cardiovascular risk stratification, and potential plaque-screening approaches in Pakistan, all of which can ultimately help reduce the burden of CHD in the country. In this report investigators describe the rationale, objectives, methods, and discuss the potential implications of the PAK-SEHAT study.
CONDITIONS
Official Title
Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Native Pakistani
- Men aged 35-60 years and women aged 35-65 years
- Willing to consent to participation
You will not qualify if you...
- eGFR less than 60 ml/min/1.73m2
- Pregnant women
- History of stroke or myocardial infarction (including CABG or PCI)
- History of peripheral arterial disease
- Weight more than 102 Kg
- Any active malignancy
- Known contraindication to contrast used in cardiac CT angiography
- Expected to move away from residential area within 5 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tabba Heart Institute
Karachi, Sindh, Pakistan, 74500
Actively Recruiting
Research Team
B
Bashir Hanif, FSCAI
CONTACT
G
Ghazal Peerwani, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here